Business Description
Nang Kuang Pharmaceutical Co Ltd
ISIN : TW0001752004
Total Employee Number:
552Description
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.54 | |||||
Equity-to-Asset | 0.65 | |||||
Debt-to-Equity | 0.26 | |||||
Debt-to-EBITDA | 1.36 | |||||
Interest Coverage | 34.41 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 2.74 | |||||
Beneish M-Score | -2.95 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.7 | |||||
3-Year EBITDA Growth Rate | -6.6 | |||||
3-Year EPS without NRI Growth Rate | -11.7 | |||||
3-Year FCF Growth Rate | -12.7 | |||||
3-Year Book Growth Rate | 1 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 17.31 | |||||
9-Day RSI | 27.45 | |||||
14-Day RSI | 32.56 | |||||
3-1 Month Momentum % | -7.83 | |||||
6-1 Month Momentum % | -9.97 | |||||
12-1 Month Momentum % | -5.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.4 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.33 | |||||
Days Inventory | 170.66 | |||||
Days Sales Outstanding | 45.54 | |||||
Days Payable | 56.37 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 5.05 | |||||
Dividend Payout Ratio | 0.67 | |||||
3-Year Dividend Growth Rate | -3.9 | |||||
Forward Dividend Yield % | 5.05 | |||||
5-Year Yield-on-Cost % | 5.03 | |||||
Shareholder Yield % | -0.38 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.56 | |||||
Operating Margin % | 13.67 | |||||
Net Margin % | 11.3 | |||||
EBITDA Margin % | 22.33 | |||||
FCF Margin % | 8.47 | |||||
OCF Margin % | 21.46 | |||||
ROE % | 10.14 | |||||
ROA % | 6.4 | |||||
ROIC % | 8.38 | |||||
3-Year ROIIC % | -8.94 | |||||
ROC (Joel Greenblatt) % | 11.98 | |||||
ROCE % | 11.23 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.06 | |||||
Forward PE Ratio | 15.06 | |||||
PE Ratio without NRI | 13.06 | |||||
Shiller PE Ratio | 12.82 | |||||
Price-to-Owner-Earnings | 19.03 | |||||
PEG Ratio | 5.22 | |||||
PS Ratio | 1.47 | |||||
PB Ratio | 1.28 | |||||
Price-to-Tangible-Book | 1.28 | |||||
Price-to-Free-Cash-Flow | 17.34 | |||||
Price-to-Operating-Cash-Flow | 6.85 | |||||
EV-to-EBIT | 11.6 | |||||
EV-to-EBITDA | 7.2 | |||||
EV-to-Revenue | 1.61 | |||||
EV-to-FCF | 19.24 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Price-to-Graham-Number | 0.86 | |||||
| Price-to-Net-Current-Asset-Value | 20.63 | |||||
Earnings Yield (Greenblatt) % | 8.62 | |||||
FCF Yield % | 5.78 | |||||
Forward Rate of Return (Yacktman) % | 7.34 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nang Kuang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 2,162.218 | ||
| EPS (TTM) (NT$) | 2.4 | ||
| Beta | -0.1595 | ||
| 3-Year Sharpe Ratio | -1.2 | ||
| 3-Year Sortino Ratio | -1.38 | ||
| Volatility % | 11.68 | ||
| 14-Day RSI | 32.56 | ||
| 14-Day ATR (NT$) | 0.54097 | ||
| 20-Day SMA (NT$) | 32.465 | ||
| 12-1 Month Momentum % | -5.86 | ||
| 52-Week Range (NT$) | 31.3 - 40.7 | ||
| Shares Outstanding (Mil) | 100.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nang Kuang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nang Kuang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 1.600000 Cash Dividend | 2026-07-02 | 33.20 (-0.90%) | ||
| TWD 1.600000 Cash Dividend | 2025-07-03 | 36.65 (+0.69%) |
Show
Entries
Nang Kuang Pharmaceutical Co Ltd Frequently Asked Questions
What is Nang Kuang Pharmaceutical Co Ltd(TPE:1752)'s stock price today?
The current price of TPE:1752 is NT$31.35. The 52 week high of TPE:1752 is NT$40.70 and 52 week low is NT$31.30.
When is next earnings date of Nang Kuang Pharmaceutical Co Ltd(TPE:1752)?
The next earnings date of Nang Kuang Pharmaceutical Co Ltd(TPE:1752) is .
Does Nang Kuang Pharmaceutical Co Ltd(TPE:1752) pay dividends? If so, how much?
The Dividend Yield %  of Nang Kuang Pharmaceutical Co Ltd(TPE:1752) is 5.05% (As of Today), Highest Dividend Payout Ratio of Nang Kuang Pharmaceutical Co Ltd(TPE:1752) was 0.86. The lowest was 0.51. And the median was 0.75. The  Forward Dividend Yield % of Nang Kuang Pharmaceutical Co Ltd(TPE:1752) is 5.05%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Nang Kuang Pharmaceutical Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers